FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to a composition having activity against gram-positive bacteria, containing a combination of ramisol or chlopam with penicillin or cephem; as well as use of said compounds for preparing a composition for suppressing, inhibiting, preventing, ameliorating or treating a gram-positive bacterial infection; to a method of suppressing, inhibiting, preventing, ameliorating or treating a gram-positive bacterial infection; to a method of monitoring or manipulating a population of gram-positive commensal bacteria; to a method of delaying or preventing the development of antibiotic resistance of gram-positive bacteria; to a method of preventing, removing or monitoring gram-positive bacterial contamination; and to a pharmaceutical composition having activity against gram-positive bacteria.
EFFECT: group of inventions provides a synergetic action on gram-positive bacteria.
27 cl, 1 ex, 33 tbl
Title | Year | Author | Number |
---|---|---|---|
CEFTAROLINE-INCLUDING COMPOSITIONS AND METHODS OF TREATMENT | 2009 |
|
RU2524665C2 |
COMBINATIONS OF BACTERIOPHAGE LYSINE AND ANTIBIOTICS AGAINST GRAM-POSITIVE BACTERIA | 2013 |
|
RU2659208C2 |
COMBINED THERAPEUTIC AGENTS CONTAINING OXAZOLIDINONES-QUINOLONES INTENDED FOR TREATMENT OF BACTERIAL INFECTIONS | 2014 |
|
RU2675847C2 |
BIOFILM PREVENTION, DESTRUCTION AND TREATMENT BY BACTERIOPHAGE LYSIN | 2013 |
|
RU2646102C2 |
SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[6-FLUORO-5-[2-(1-HYDROXY-1-METHYL-ETHYL) PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL] UREA | 2012 |
|
RU2625305C2 |
STRAIN OF STAPHYLOCOCCUS AUREUS CHARACTERIZED BY RESISTANCE TO DAPTOMYCIN AND USED AS A CONTROL TEST CULTURE TO DETERMINE ANTIBIOTIC SENSITIVITY | 2022 |
|
RU2809847C1 |
PREVENTION, DESTRUCTION AND TREATMENT OF BIOFILM BY BACTERIOPHAGE LYSINE | 2013 |
|
RU2735103C2 |
NOVEL ANTIBACTERIAL MEDICATIONS FOR TREATMENT OF GRAM-POSITIVE INFECTIONS | 2009 |
|
RU2512396C2 |
SOLUBLE PHARMACEUTICAL COMPOSITION FOR MASTITIS AND EAR INVOLVEMENT TREATMENT | 2004 |
|
RU2329064C2 |
COMPOUNDS FOR TREATING CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES | 2011 |
|
RU2575477C2 |
Authors
Dates
2020-11-17—Published
2016-08-29—Filed